A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.


YALÇIN B., ÜNER A. , AKBULUT H., İÇLİ F., IŞIKDOĞAN A., BÜYÜKÇELİK A., ...Daha Fazla

Proceedings of European Society of Clinical Oncology, 18 - 22 Ekim 2002